For patients with neuroendocrine tumors (NETs), the development of liver metastases is a pivotal event, occurring in 9 of 10 cases. The control of these metastases is the primary determinant of both patient survival and symptomatic relief….
RETNET: Exploring Therapies for Liver Metastases in NETs | Targeted Oncology
